Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature

<p>Refinement and Evaluation of a Chinese and Western Medication Adherence Scale for Patients with Chronic Kidney Disease: Item Response Theory Analyses</p>

“…Medication adherence, therefore importantly, refers to the extent to which a patient's medication behavior conforms to the agreed recommendations from a healthcare provider. 3 Evidence to date has documented that estimates of nonadherence to medication among CKD patients varies from 17-80%, 4,5 and poor medication adherence is associated with the reduced expected medication effects or even increased incident adverse events. 6 Herbal medication of traditional Chinese medicine (TCM) has been increasingly added into regular CKD regimen as accumulating evidence these days has supported its potential benefits on the reduced ESRD and death risk of CKD patients.…”

Implications of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: A Proposed Observational Investigation by the Fail-to-Refill Project

“…4 Poor adherence to medications indicated for chronic conditions such as hypertension, hypercholesterolaemia, diabetes mellitus, osteoporosis, chronic kidney disease and chronic obstructive pulmonary disease is welldocumented in literature. [5][6][7][8][9][10][11] Recent evidence demonstrated that the tendency of poor medication adherence is also reported for biologic therapies indicated for instance to manage rheumatoid arthritis, psoriasis or cancer. 12 The conditions of use are also important for treatment success, as the administration of drugs without following provider recommendations compromises the effectiveness of the therapeutic regimen, leading to suboptimal clinical benefits and negative outcomes such as disease progression, reduced functional abilities and a lower quality of life.…”

Electronic Monitoring Feedback for Improving Medication Adherence and Clinical Outcomes in Early Rheumatoid Arthritis: A Randomized Clinical Trial

“…14 Several barriers to adequate medication intake might exist in patients with chronic conditions, such as therapy-related factors, condition-related factors, patient-related factors, socio-economic factors, and health system-related factors. [18][19][20][21] EMF provides the opportunity to identify such barriers to adequate medication intake, thereby anticipating the large (intraand interpatient) variety over time. The barriers identified during these feedback conversations can subsequently act as targets for intervening for individual patients.…”